Mathieu Nonnenmacher
Voyager Therapeutics (United States)(US)
Publications by Year
Research Areas
Virus-based gene therapy research, CRISPR and Genetic Engineering, RNA Interference and Gene Delivery, Cardiomyopathy and Myosin Studies, Pluripotent Stem Cells Research
Most-Cited Works
- → Intracellular transport of recombinant adeno-associated virus vectors(2012)236 cited
- → Adeno-Associated Virus 2 Infection Requires Endocytosis through the CLIC/GEEC Pathway(2011)190 cited
- → Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy(2015)186 cited
- → Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning(2020)165 cited
- → Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression(2015)108 cited
- → Cardiac Stim1 Silencing Impairs Adaptive Hypertrophy and Promotes Heart Failure Through Inactivation of mTORC2/Akt Signaling(2016)92 cited
- → Syntaxin 5-Dependent Retrograde Transport to the trans -Golgi Network Is Required for Adeno-Associated Virus Transduction(2014)87 cited
- → Genomic correction of familial cardiomyopathy in human engineered cardiac tissues(2016)78 cited
- → Effectiveness of gene delivery systems for pluripotent and differentiated cells(2015)65 cited
- → Gene editing reverses arrhythmia susceptibility in humanized PLN-R14del mice: modelling a European cardiomyopathy with global impact(2022)55 cited